Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+...
-
Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Filtration Market (Focus on Biologics Manufacturing): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Filtration, Type of...
-
AGOURA HILLS, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) (“Oncotelic”, the “Company” or “We”), a clinical-stage biopharmaceutical company developing drugs...
-
Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Stability Testing of Pharmaceuticals and Biopharmaceuticals (May 20th - May 22nd, 2026)" training has been added to ResearchAndMarkets.com's...
-
Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Modern Agile Leadership for Pharma and Biopharma Professionals: Adapting to a Changing Workplace (May 11th - May 12th, 2026)" training has been added...
-
Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products (Apr 23rd - Apr 24th, 2026)" training has been added...
-
Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Biopharmaceutical CXO Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The Biopharmaceutical CXO...
-
Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Bio/Pharmaceutical Outsourcing Report, February 2026" report has been added to ResearchAndMarkets.com's offering.The Bio/Pharmaceutical Outsourcing...
-
PONTE VEDRA, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and...
-
Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "Microbiome - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report offers a detailed analysis of over 140...